文献速递肝病

能量限制与运动后的组织学改善:胰岛素抵抗在MASH缓解中的作用

Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH.
PubMed 文献 · J Hepatol · 2024-06-22

该研究将MASH患者随机分为治疗组(n=16)和对照组(n=8),治疗组接受10个月能量限制联合监督下高强度间歇训练(每周3次),对照组继续医生指导的常规护理。治疗组体重、脂肪量和肝损伤显著降低,VO2peak改善,外周胰岛素敏感性较对照组增加两倍,且与肝病缓解显著相关。

要点

  • 10个月能量限制联合监督下高强度间歇训练(每周3次)可显著降低MASH患者体重、脂肪量和肝损伤。
  • 治疗组外周胰岛素敏感性较对照组增加两倍,且与较高的VO2peak和肝病缓解显著相关。
  • 两组均出现总能量摄入、血红蛋白A1c、肝脏胰岛素抵抗和肝脏脂肪的降低(p<0.05)。

核心结论

  • 运动联合能量限制对肝脏健康产生显著且具有临床意义的治疗效果,可能由过剩营养重新分布至骨骼肌、减少肝脏营养毒性所驱动。
  • 临床指南应强调在MASH生活方式治疗中加入有氧运动,以使晚期MASH个体获得最大组织学获益。

研究设计与样本

  • 研究为随机对照试验,MASH医学诊断后个体随机分为治疗组(n=16)和对照组(n=8)。
  • 治疗组接受能量摄入减少咨询并完成监督下高强度间歇训练(每周3次),共10个月;对照组继续医生指导的常规护理。
  • 干预前后完成肝脏脂肪磁共振波谱、18小时血浆生化测量和同位素标记高胰岛素-正葡萄糖钳夹;干预中期测量体成分和心肺适能(VO2peak)。

主要发现

  • 治疗组体重、脂肪量和肝损伤显著降低(p<0.05),VO2peak改善(p<0.05),非酯化脂肪酸抑制改善(p=0.06)。
  • 两组均出现总能量摄入、血红蛋白A1c、肝脏胰岛素抵抗和肝脏脂肪降低(p<0.05)。
  • 与对照组相比,治疗组外周胰岛素敏感性增加两倍,且与较高的VO2peak和肝病缓解显著相关。

临床怎么用

  • 作者认为,临床指南应强调在MASH生活方式治疗中加入有氧运动,以使晚期MASH个体获得最大组织学获益。
  • 作者认为,肝外底物处置和适能水平改善支持组织学改善,证实加入运动对MASH生活方式干预至关重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Metabolic dysfunction-associated steatohepatitis (MASH) is one of the most common liver diseases worldwide and is characterized by multi-tissue insulin resistance. The effects of a 10-month energy restriction and exercise intervention on liver histology, anthropometrics, plasma biochemistries, and insulin sensitivity were compared to standard of care (control) to understand mechanisms that support liver health improvements. METHODS: Following medical diagnosis of MASH, individuals were randomized to treatment (n = 16) or control (n = 8). Liver fat (magnetic resonance spectroscopy), 18-hour plasma biochemical measurements, and isotopically labeled hyperinsulinemic-euglycemic clamps were completed pre- and post-intervention. Body composition and cardiorespiratory fitness (VO2peak) were also measured mid-intervention. Those in the treatment group were counseled to reduce energy intake and completed supervised, high-intensity interval training (3x/week) for 10 months. Controls continued physician-directed care. RESULTS: Treatment induced significant (p <0.05) reductions in body weight, fat mass, and liver injury, while VO2peak (p <0.05) and non-esterified fatty acid suppression (p = 0.06) were improved. Both groups exhibited reductions in total energy intake, hemoglobin A1c, hepatic insulin resistance, and liver fat (p <0.05). Compared to control, treatment induced a two-fold increase in peripheral insulin sensitivity which was significantly related to higher VO2peak and resolution of liver disease. CONCLUSIONS: Exercise and energy restriction elicited significant and clinically meaningful treatment effects on liver health, potentially driven by a redistribution of excess nutrients to skeletal muscle, thereby reducing hepatic nutrient toxicity. Clinical guidelines should emphasize the addition of aerobic exercise in lifestyle treatments for the greatest histologic benefit in individuals with advanced MASH. IMPACT AND IMPLICATIONS: The mechanisms that underpin histologic improvement in individuals with metabolic dysfunction-associated steatohepatitis (MASH) are not well understood. This study evaluated the relationship between liver and metabolic health, testing how changes in one may affect the other. We investigated the effects of energy restriction and exercise on the association between multi-tissue insulin sensitivity and histologic improvements in participants with biopsy-proven MASH. For the first time, these results show that an improvement in peripheral (but not hepatic) insulin sensitivity and systemic markers of muscle function (i.e. cardiorespiratory fitness) were strongly related to resolution of liver disease. Extrahepatic disposal of substrates and improved fitness levels supported histologic improvement, confirming the addition of exercise as crucial to lifestyle interventions in MASH. CLINICAL TRIAL NUMBER: NCT03151798.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Mucinski JM, Salvador AF, Moore MP, et al. Histological improvements following energy restriction and exercise: The role of insulin resistance in resolution of MASH. J Hepatol. 2024. PMID: 38914313. doi:10.1016/j.jhep.2024.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。